Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: The Spanish bladder cancer study

International Journal of Cancer

Volumn 133, Issue 3, 2013, Pages 597-603

  Robles, Claudia ^a   Viscidi, Raphael ^b   Malats, Nuria ^c   Silverman, Debra T ^d   Tardon, Adonina ^e,f   Garcia Closas, Reina ^g   Serra, Consol ^h   Carrato, Alfredo ^i,j   Herranz, Jesús ^c   Lloreta, Josep ^k   Rothman, Nathaniel ^d   Real, Francisco X ^c,l   De Sanjose, Silvia ^a,f   Kogevinas, Manolis ^f,k,m,n  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF OVIEDO   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^h Department of Pediatrics   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL DEL MAR   (Spain)

^l UNIVERSITAT POMPEU FABRA   (Spain)

^m NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

ⁿ CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

more..

Author keywords

BK polyomavirus; JCV polyomavirus and bladder cancer; Merkel cell polyomavirus; seroepidemiology

Indexed keywords

BK VIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; JC VIRUS ANTIBODY; MERKEL CELL POLYOMAVIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BK VIRUS; BK VIRUS INFECTION; BLADDER CARCINOMA; CANCER GRADING; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOREACTIVITY; JC VIRUS; JC VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL POLYOMAVIRUS INFECTION; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SPAIN; TRANSITIONAL CELL CARCINOMA; VIRUS LIKE AGENT;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BK VIRUS; FEMALE; HUMANS; JC VIRUS; MALE; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RISK; SEROEPIDEMIOLOGIC STUDIES; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS;

EID: 84878020944     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28053     Document Type: Article

References (25)

1. Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr, accessed on 16/11/2012.
2. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005; 366: 649-59.
3. Kogevinas M, Garcia-Closas M, Trichopoulos D,. Urinary bladder cancer. In:, Adami H, Hunter D, Trichopoulos D, eds. Textbook of Cancer epidemiology. New York: Oxford University Press, 2008: 573-96.
4. Silverman D, Devesa S, Moore L, et al. Bladder cancer. In:, Schottenfeld D, Fraumeni JJ, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 2006.
5. Bouvard V, Baan RA, Grosse Y, et al. Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol 2012; 13: 339-40.
6. Gjoerup O, Chang Y,. Update on human polyomaviruses and cancer. Adv Cancer Res 2010; 106: 1-51.
7. Husseiny MI, Anastasi B, Singer J, et al. A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. J Clin Virol 2010; 49: 137-40.
8. Newton R, Ribeiro T, Casabonne D, et al. Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. Br J Cancer 2005; 93: 1305-6.
9. Polesel J, Gheit T, Talamini R, et al. Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 2012; 106: 222-6.
10. Weinreb DB, Desman GT, Amolat-Apiado MJ, et al. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006; 34: 201-3.
11. Roberts IS, Besarani D, Mason P, et al. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer 2008; 99: 1383-6.
12. Guey LT, Garcia-Closas M, Murta-Nascimento C, et al. Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol 2010; 57: 283-92.
13. Randhawa PS, Gupta G, Vats A, et al. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 2006; 13: 1057-63.
14. Viscidi RP, Khanna N, Tan CS, et al. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis 2011; 53: 711-5.
15. Viscidi RP, Rollison DE, Sondak VK, et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011; 18: 1737-43.
16. Viscidi RP, Rollison DE, Viscidi E, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003; 10: 278-85.
17. Tolstov YL, Knauer A, Chen JG, et al. Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis 2011; 17: 1371-80.
18. Monini P, Rotola A, Di Luca D, et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology 1995; 214: 273-9.
19. Fioriti D, Pietropaolo V, Dal Forno S, et al. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003; 16: 283-8.
20. Rollison DE, Sexton WJ, Rodriguez AR, et al. Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer 2007; 120: 1248-51.
21. Loyo M, Guerrero-Preston R, Brait M, et al. Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer 2010; 126: 2991-6.
22. Robles C, Poloczek A, Casabonne D, et al. Antibody response to Merkel cell polyomavirus associated with incident lymphoma in the Epilymph case-control study in Spain. Cancer Epidemiol Biomarkers Prev 2012; 21: 1592-8.
23. IARC monographs on the evaluation of carcinogenic risks to humans: Tobacco smoke and involuntary smoking, 2004 ed., vol. 83. Lyon: IARC Press, 2004.
24. Huttunen R, Heikkinen T, Syrjanen J,. Smoking and the outcome of infection. J Intern Med 2011; 269: 258-69.
25. Touze A, Gaitan J, Arnold F, et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol 2010; 48: 1767-70.